VIVOZON PHARMACEUTICAL CO., LTD.

Develops innovative, non-narcotic drugs for pain and central nervous system (CNS) diseases.

082800 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 화성시 향남읍 제약공단2길 34-40, 화성시
Website:: https://www.vivozon.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Vivozon Pharmaceutical Co., Ltd. is a global drug development company established in 2008, focused on creating innovative treatments for pain and central nervous system (CNS) diseases. The company's core research centers on a multi-target drug discovery platform designed to develop chemical drugs with synergistic efficacy. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic. Vivozon utilizes an efficacy-based screening system from the early stages of discovery to advance its pipeline, which also targets conditions such as depression, substance use disorders, and neurodegenerative diseases.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for VIVOZON PHARMACEUTICAL CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all VIVOZON PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for VIVOZON PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AcuCort AB Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.	Sweden	ACUC
ADBIOTECH Co.,Ltd. Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.	South Korea	179530
Advicenne Develops and commercializes therapies for rare renal diseases for patients of all ages.	France	ALDVI
AegirBio AB Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.	Sweden	AEGIR
Aelis Farma Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.	France	AELIS
AFC-HD AMS Life Science Co.,Ltd. An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.	Japan	2927
ALK-Abelló Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.	Denmark	ALK
Alkaloid AD Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.	North Macedonia	ALK
ALLERGY THERAPEUTICS PLC Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.	United Kingdom	AGY
Alligator Bioscience Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.	Sweden	ATORX